Donor, Autologous Stem Cells Equally Safe for Cardiomyopathy

This study was funded by the National Heart, Lung, and Blood Institute and the National Institutes of Health; Biocardia supplied the cardiac infusion catheters. Dr. Hare reported holding a patent for cardiac cell-based therapy and having ties to Biocardia, Vestion, and Kardia, and his associates reported ties to numerous industry sources.